Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A primary aromatic amine is an organic compound in which an amine group (–NH₂) is directly attached to an aromatic ring, typically a benzene ring (e.g., aniline, C₆H₅NH₂)[6][2][5]. Unlike aliphatic amines, aromatic amines have their nitrogen atom's lone pair electrons partially delocalized into the ring, leading to reduced basicity compared to aliphatic primary amines[2][3]. These compounds are widely used industrially as precursors in the manufacture of dyes, pharmaceuticals, pesticides, and polymers[6]. Primary aromatic amines are not a biological macromolecule, receptor, enzyme, or typical drug target—they are a chemical class—not a single defined molecular target. They present significant toxicological and occupational hazards, with several members classified as probable or known human carcinogens, mutagens, or sensitizers[8][2][6]. These compounds are subject to strict regulation in consumer products due to their potential health effects[6][8]. Additional notes: - "Primary aromatic amine" is not the name of a specific molecular target or receptor (such as a protein or enzyme), but a class of chemical compounds. - The correct approach for medicinal chemistry or pharmaceutical research is to address specific molecules within this class (e.g., "Aniline", "4-Aminobiphenyl", "o-Toluidine"), not the entire class. - Aliases refer to overlapping terminology. Sometimes "arylamine" is used interchangeably with "aromatic amine", but technically encompasses any amine where nitrogen is bonded directly to an aromatic ring[6]. - If patient or drug selection is based on metabolism or toxicity involving these compounds, relevant protein targets would be enzymes such as N-acetyltransferases (e.g., NAT2), not aromatic amines themselves. Summary: "Primary aromatic amine" is a generic chemical classification, not a valid molecular or therapeutic target, and thus is not suitable for a drug target database or as a "receptor" entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Primary aromatic amine.